FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

NIH research cuts leave cancer patient facing hard choice

2.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

3.

AI Model as Effective as Radiologists in Detecting Prostate Cancer on MRI

4.

Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery

5.

New surgical method shows promising results for cervical cancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot